4-CHLORO-5-METHOXY-1H-PYRROLO[2,3-B]PYRIDINE, 95.0%, 100mg

2,5-dichloro-4-(3-methyl-5-oxo-2,5-dihydro-1H-pyrazol-1-yl)benzene-1-sulfonic acid, 90+%, 5g

N1,N4-Di(naphthalen-2-yl)benzene-1,4-diamine, 96.0%, 100g

1-(2-Bromo-6-hydroxyphenyl)ethanone, 95.0%, 250mg

4-((4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)sulfonyl)morpholine, 98%, 25g

2-carboethoxy-3'-pyrrolidinomethyl benzophenone, 97.0%, 1g

1,4-dimethyl-4-piperidinecarbaldehyde hydrochloride, 95.0%, 1g

Methyl 4-bromo-2-methoxybenzoate, 95.0%, 1g

Warning symbol according to ISO 7010 Individual label, Magnetic field, Side length 100 mm, 1 piece

3-Azabicyclo[3.2.1]octan-2-one, 95.0%, 100mg

4-[(1-methylpyrrolidin-3-yl)oxy]piperidine, 95.0%, 250mg

7-Bromoimidazo[1,2-a]pyridin-2-amine, 97%, 250mg

Oxygen bottles, 250 to 300 ml, 19/26, 1 Piece